Chemoinformaics analysis of ANTHRANILIC-ACID-METHYL-ETHER
| Molecular Weight | 430.497 | nRot | 11 |
| Heavy Atom Molecular Weight | 400.257 | nRig | 14 |
| Exact Molecular Weight | 430.199 | nRing | 2 |
| Solubility: LogS | -2.954 | nHRing | 0 |
| Solubility: LogP | 6.638 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 65.6978 |
| nHD | 4 | BPOL | 33.5682 |
| QED | 0.22 |
| Synth | 2.64 |
| Natural Product Likeliness | 0.859 |
| NR-PPAR-gamma | 0.936 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.013 |
| HIA | 0.064 |
| CACO-2 | -5.36 |
| MDCK | 0.0000255 |
| BBB | 0.046 |
| PPB | 1.00264 |
| VDSS | 0.231 |
| FU | 0.00525249 |
| CYP1A2-inh | 0.658 |
| CYP1A2-sub | 0.156 |
| CYP2c19-inh | 0.217 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.598 |
| CYP2c9-sub | 0.252 |
| CYP2d6-inh | 0.826 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.181 |
| CYP3a4-sub | 0.016 |
| CL | 3.156 |
| T12 | 0.823 |
| hERG | 0.258 |
| Ames | 0.052 |
| ROA | 0.059 |
| SkinSen | 0.831 |
| Carcinogencity | 0.034 |
| EI | 0.857 |
| Respiratory | 0.53 |
| NR-Aromatase | 0.022 |
| Antiviral | Yes |
| Prediction | 0.66024 |